Pharma Co. Asks For Stay To Appeal 'Orange Book' Delisting
By Kelly Lienhard · November 23, 2022, 4:38 PM EST
Jazz Pharmaceuticals has asked a Delaware federal court to pause an order requiring it to ask the U.S. Food and Drug Administration to pull a patent that purportedly covers the distribution...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login